Sinil Pharmaceutical Co., Ltd.

Informe acción KOSDAQ:A012790

Capitalización de mercado: ₩80.1b

Sinil Pharmaceutical Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Mi-Keun Jung

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEO0.9%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directivasin datos

Actualizaciones recientes de la dirección

Recent updates

Are Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Mixed Financials Driving The Negative Sentiment?

Mar 11
Are Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Mixed Financials Driving The Negative Sentiment?

Is Sinil Pharmaceutical's (KOSDAQ:012790) 122% Share Price Increase Well Justified?

Feb 13
Is Sinil Pharmaceutical's (KOSDAQ:012790) 122% Share Price Increase Well Justified?

Could The Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790) Ownership Structure Tell Us Something Useful?

Jan 17
Could The Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790) Ownership Structure Tell Us Something Useful?

Sinil Pharmaceutical's (KOSDAQ:012790) Earnings Are Growing But Is There More To The Story?

Dec 22
Sinil Pharmaceutical's (KOSDAQ:012790) Earnings Are Growing But Is There More To The Story?

Are Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?

Nov 26
Are Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?

CEO

Mi-Keun Jung (69 yo)

no data

Permanencia

Mr. Mi-Geun Jung serves as the Chief Executive Officer and President at Shinil Pharmaceutical Co., Ltd. Mr. Jung served as a Vice President and Factory Manager of Shinil Pharmaceutical Co., Ltd. He served...